OncLive Welcomes Stephenson Cancer Center to Strategic Alliance Partnership Program

Published: Monday, Jan 12, 2015
PLAINSBORO, N.J. – January 12, 2015 – OncLive® and Stephenson Cancer Center, the only comprehensive academic cancer center in Oklahoma, have become partners in raising the standard of cancer care through OncLive’s Strategic Alliance Partnership program, OncLive announced today.

Through the Strategic Alliance Partnership program, the OncLive editorial and marketing teams will work with Stephenson Cancer Center to raise awareness of Stephenson’s innovative approach to cancer research, care and educational efforts.

The Stephenson Cancer Center promotes cutting-edge cancer research in a patient-centered environment, while also advancing educational efforts on campus and in its communities. Research is an integral part of developing new therapies and improving cancer treatment. Combining the best practices in patient care and the latest in research and technology, each Stephenson patient receives a unique treatment plan with the support team of multi-disciplinary specialist to help them navigate through treatment and recovery.

Under the guidance of Robert Mannel, M.D., Director, the mission of the Stephenson is to improve and extend the lives of cancer patients through providing patient-centered, comprehensive care, conducting innovative basic, translational, and clinical research, raising the level of cancer awareness and prevention, educating the next generation of cancer health care professionals, and serving as a statewide resource for patients, researchers, health professionals, and communities.

Mike J. Hennessy Jr., Senior Vice President, Oncology & Specialty Pharmacy, said, “We are delighted to partner with the Stephenson Cancer Center, Oklahoma’s outstanding academic cancer center with faculty from Oklahoma University Health Sciences Center, OU Norman, OU Tulsa, Oklahoma State University and the Oklahoma Medical Research Foundation. These members share a common goal to reduce the morbidity and mortality caused by cancer in Oklahoma and beyond.”

“Stephenson joins more than 30 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive,” Hennessy said. “These partnerships benefit all levels of healthcare professionals dedicated to combating cancer as well as the patients they serve. By collaborating, sharing information and working together, we broaden opportunities to find the best approaches to fighting cancer.”

About OncLive®

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. OncLive® offers oncology professionals with resources and information to provide the best care for their patients. Intellisphere, LLC, a leading provider of health care publishing, research, and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, NJ. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers, and advocacy groups. To learn more, please visit www.OncLive.com.

About The Stephenson Cancer Center

The Stephenson Cancer Center, located at the Oklahoma Health Sciences Center Campus in Oklahoma City, is home to precision medicine in Oklahoma, offering the best in patient care and clinical research. This multi-faceted approach to medicine means creating individualized treatment plans for each patient based on their unique health characteristics and diagnosis. The center conducts innovative and nationally-funded cancer research in the basic, clinical and population sciences. To learn more, please visit www.stephensoncancercenter.org.


Media Contact for OncLive:

Becky Taylor, 609.240.6886, becky@btaylorpa.com

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication